Liabilities and Equity in USD of ABERCROMBIE & FITCH CO /DE/ from Q4 2009 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
ABERCROMBIE & FITCH CO /DE/ quarterly Liabilities and Equity history and change rate from Q4 2009 to Q3 2025.
  • ABERCROMBIE & FITCH CO /DE/ Liabilities and Equity for the quarter ending 01 Nov 2025 was $3.48B, a 6.42% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

ABERCROMBIE & FITCH CO /DE/ Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $3.48B +$210M +6.42% 01 Nov 2025 10-Q 05 Dec 2025
Q2 2025 $3.3B +$252M +8.28% 02 Aug 2025 10-Q 05 Sep 2025
Q1 2025 $3.1B +$126M +4.25% 03 May 2025 10-Q 06 Jun 2025
Q4 2024 $3.3B +$326M +10.9% 01 Feb 2025 10-Q 05 Dec 2025
Q3 2024 $3.27B +$372M +12.8% 02 Nov 2024 10-Q 06 Dec 2024
Q2 2024 $3.05B +$253M +9.04% 03 Aug 2024 10-Q 06 Sep 2024
Q1 2024 $2.97B +$412M +16.1% 04 May 2024 10-Q 07 Jun 2024
Q4 2023 $2.97B +$261M +9.63% 03 Feb 2024 10-K 31 Mar 2025
Q3 2023 $2.9B +$204M +7.56% 28 Oct 2023 10-Q 04 Dec 2023
Q2 2023 $2.8B +$62.6M +2.29% 29 Jul 2023 10-Q 01 Sep 2023
Q1 2023 $2.56B -$49.2M -1.89% 29 Apr 2023 10-Q 06 Jun 2023
Q4 2022 $2.71B -$226M -7.7% 28 Jan 2023 10-K 01 Apr 2024
Q3 2022 $2.69B -$419M -13.4% 29 Oct 2022 10-Q 06 Dec 2022
Q2 2022 $2.73B -$321M -10.5% 30 Jul 2022 10-Q 07 Sep 2022
Q1 2022 $2.61B -$463M -15.1% 30 Apr 2022 10-Q 08 Jun 2022
Q4 2021 $2.94B -$375M -11.3% 29 Jan 2022 10-K 27 Mar 2023
Q3 2021 $3.11B -$164M -5.02% 30 Oct 2021 10-Q 06 Dec 2021
Q2 2021 $3.06B -$253M -7.66% 31 Jul 2021 10-Q 08 Sep 2021
Q1 2021 $3.07B -$221M -6.72% 01 May 2021 10-Q 09 Jun 2021
Q4 2020 $3.31B -$235M -6.61% 30 Jan 2021 10-K 28 Mar 2022
Q3 2020 $3.28B -$209M -6% 31 Oct 2020 10-Q 07 Dec 2020
Q2 2020 $3.31B -$98.2M -2.88% 01 Aug 2020 10-Q 08 Sep 2020
Q1 2020 $3.29B -$131M -3.83% 02 May 2020 10-Q 10 Jun 2020
Q4 2019 $3.55B +$1.16B +48.8% 01 Feb 2020 10-K 29 Mar 2021
Q3 2019 $3.49B +$1.2B +52.7% 02 Nov 2019 10-Q 11 Dec 2019
Q2 2019 $3.41B +$1.15B +50.7% 03 Aug 2019 10-Q 11 Sep 2019
Q1 2019 $3.42B +$1.21B +54.8% 04 May 2019 10-Q 12 Jun 2019
Q4 2018 $2.39B +$59.9M +2.58% 02 Feb 2019 10-K 31 Mar 2020
Q3 2018 $2.28B -$14.8M -0.65% 03 Nov 2018 10-Q 12 Dec 2018
Q2 2018 $2.26B +$32.9M +1.48% 04 Aug 2018 10-Q 10 Sep 2018
Q1 2018 $2.21B +$53.6M +2.48% 05 May 2018 10-Q 08 Jun 2018
Q4 2017 $2.33B +$29.9M +1.3% 03 Feb 2018 10-K 01 Apr 2019
Q3 2017 $2.3B -$38.6M -1.65% 28 Oct 2017 10-Q 04 Dec 2017
Q2 2017 $2.23B -$104M -4.48% 29 Jul 2017 10-Q 05 Sep 2017
Q1 2017 $2.16B -$186M -7.94% 29 Apr 2017 10-Q 06 Jun 2017
Q4 2016 $2.3B -$137M -5.64% 28 Jan 2017 10-K 02 Apr 2018
Q3 2016 $2.34B -$176M -7.02% 29 Oct 2016 10-Q 05 Dec 2016
Q2 2016 $2.33B -$89.8M -3.71% 30 Jul 2016 10-Q 06 Sep 2016
Q1 2016 $2.34B -$20.4M -0.86% 30 Apr 2016 10-Q 06 Jun 2016
Q4 2015 $2.43B -$72.1M -2.88% 30 Jan 2016 10-K 27 Mar 2017
Q3 2015 $2.51B -$62.8M -2.44% 31 Oct 2015 10-Q 07 Dec 2015
Q2 2015 $2.42B -$141M -5.5% 01 Aug 2015 10-Q 10 Sep 2015
Q1 2015 $2.36B -$202M -7.86% 02 May 2015 10-Q 08 Jun 2015
Q4 2014 $2.51B -$346M -12.1% 31 Jan 2015 10-K 28 Mar 2016
Q3 2014 $2.58B -$277M -9.71% 01 Nov 2014 10-Q 11 Dec 2014
Q2 2014 $2.56B -$280M -9.84% 02 Aug 2014 10-Q 05 Sep 2014
Q1 2014 $2.57B -$329M -11.4% 03 May 2014 10-Q 09 Jun 2014
Q4 2013 $2.85B -$136M -4.57% 01 Feb 2014 10-K 30 Mar 2015
Q3 2013 $2.85B +$2.95M +0.1% 02 Nov 2013 10-Q 10 Dec 2013
Q2 2013 $2.84B -$26.4M -0.92% 03 Aug 2013 10-Q 09 Sep 2013
Q1 2013 $2.9B +$161M +5.89% 04 May 2013 10-Q 11 Jun 2013
Q4 2012 $2.99B -$130M -4.16% 02 Feb 2013 10-K 31 Mar 2014
Q3 2012 $2.85B -$232M -7.53% 27 Oct 2012 10-Q 04 Dec 2012
Q2 2012 $2.87B -$56.8M -1.94% 28 Jul 2012 10-Q 05 Sep 2012
Q1 2012 $2.73B -$159M -5.5% 28 Apr 2012 10-Q/A 07 Jun 2012
Q4 2011 $3.12B +$176M +5.97% 28 Jan 2012 10-K 02 Apr 2013
Q3 2011 $3.08B +$159M +5.43% 29 Oct 2011 10-Q 06 Dec 2011
Q2 2011 $2.93B +$69.2M +2.42% 30 Jul 2011 10-Q 07 Sep 2011
Q1 2011 $2.89B 30 Apr 2011 10-Q 08 Jun 2011
Q4 2010 $2.94B +$120M +4.24% 29 Jan 2011 10-K 27 Mar 2012
Q3 2010 $2.92B 30 Oct 2010 10-Q 07 Dec 2010
Q2 2010 $2.86B 31 Jul 2010 10-Q 08 Sep 2010
Q4 2009 $2.82B 30 Jan 2010 10-K 29 Mar 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.